FDA
-
-
-
-
-
-
-
CytoSorbents to Report Fourth Quarter and Full Year 2025 Financial Results and Recent Business Highlights
-
-
-
-
-
-
-
CytoSorbents to Report Third Quarter 2025 Financial Results and Recent Business Highlights
-
-
-
-
-
-
-
CytoSorbents Updates U.S. FDA Regulatory Status of DrugSorb-ATR
-
-
-
-
-
-
-
CytoSorbents Files Appeal with U.S. FDA for Supervisory Review of its De Novo Request for DrugSorb™-ATR
-
-
-
-
-
-
-
CytoSorbents to Report First Quarter 2025 Financial Results and Recent Business Highlights
-
-
-
-
-
-
-
CytoSorbents Reports Fourth Quarter and Full Year 2024 Financial Results and Recent Business Highlights
-
-
-
-
-
-
-
CytoSorbents Strengthens Balance Sheet with Closing of Oversubscribed Rights Offering
-
326,553 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

